How does Rosuvastatin influence cholesterol synthesis in genetic lipid disorders, and how effective is it in managing familial hypercholesterolemia?
Sahil KapoorExplorer
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Rosuvastatin inhibits HMG-CoA reductase, the key enzyme in cholesterol synthesis, effectively lowering LDL levels by up to 50% in familial hypercholesterolemia.